Money Viral Flashcards
DOC for chemoprophylaxis in areas with chloroquine resistant P. falciparum
- Doxycycline (Vibramycin)
Shingles (Herpes Zoster): Antiviral Therapy
- -Valacyclovir
- -Famciclovir
- -Acyclovir (5 x per day for 7 days)
DOC for Lymphatic Filariasis
- Diethylcarbamazine (DEC)
DOC for Pneumpcystis jiroveci pneumonia (PCP)
–Sulfamethoxazole-Trimethoprim (Septra)
The only FDA approved drug for treatment-experienced patients .
Drug MOA: blocks HIV fusion with the CD4 cell and block entry into the human cell
- Enfuvirtide
[Fusion Inhibitors]
Approved drug regiment for HIV Pre-Exposure Prophylaxis (PrEP)
- Emtricitabine (FTC) Daily
- PLUS-
- –Tenofovir disoproxil fumarate (TDF) (Truvada)
DOC to prevent CMV infection after transplant
- Valganciclovir (Valcyte) PO
1st line DRUGS for the treatment and prevention of Cytomegalovirus (CMV) infections
Ganciclovir (Cytovene-IV)
- Valganciclovir PO (prodrug)
DOC for Management of all HIV(+) pregnant women
ANTEPARTUM stage
- -Emtricitabine/Tenofovir (Truvada) daily
- -Raltegravir (Isentress) twice a day
HBeAg Positive
1 st Line(4-12 mos): --IFNa --PEG-IFNa 2 nd Line (>12 mos) --Entecavir or Tenofovir PO
DOC for Tx HBV
Pegasys
- -a= Preferred for HBV
- -b= FDA approved for HBV
HBeAg Negative:
1 st Line(at least 12 mos): --IFNa --PEG-IFNa 2 nd Line (>12 mos) --Entecavir or Tenofovir PO
DOC for Tx Influenza Virus in Pregnant Women
Oseltamivir
Occupational (within 72 hrs) Post-Exposure Prophylaxis (PEP) use for 28 days & nPEP
- -Emtricitabine/Tenofovir (Truvada) daily
- -Raltegravir (Isentress) twice a day
DOC in sensitive P. falciparum
- Chloroquine (Aralen)
Tx of choice of hydrocele due to Lymphatic Filariasis (e.g roundworm, elephantiasis)
- Surgery is treatment of choice for hydrocele
2nd line DRUGS for the treatment and prevention of Cytomegalovirus (CMV) infections
- Foscarnet (Foscavir) IV
- Cidofovir (Vistide) IV
DOC for Trichonomas vaginalis
–Metronidazole or Tindazole
DOC Herpes Encephalitis
- Acyclovir IV 5-10mg/kg every 8 hours for 2-7 days,
Followed by ORAL antiviral therapy for at least 10 days
DOC Genital Herpes Simplex
–Valacyclovir
Preferred treatment options for Development of Resistant HBV
Lamivudine or Telbivudine resistance : ---Add Adefovir or Tenofovir or ---Change to Entecavir Adefovir resistance : ----Add Lamivudine Entecavir resistance : ---Change to Tenofovir
Entecavir and tenofovir are preferred oral agents for what type patient populations
- -HBeAg positive
- -HBeAg negative
DOC for severe or difficult-to-treat HSV infections
- Acyclovir IV
DOC for initial mild to moderate episodes of C-diff
–Metronidazole
DOC for Management of all HIV(+) pregnant women
INTRAPARTUM stage
–add IV Zidovudine
reduces rate of mother-to-newborn transmission
HIV infant prophylaxis
- -low risk: Zidovudine 4-6 wk
- -high risk: combo regimen